Tumour necrosis factor (TNF) inhibitors have changed the therapeutic standard of treatment for patients with rheumatoid arthritis (RA), providing substantial benefits in terms of clinical and ...

Background: To analyse available evidence on the efficacy and safety of anti-TNFα drugs (infliximab, etanercept and adalimumab) for treating rheumatoid arthritis (RA). Methods: We searched ...

The effects of tumor necrosis factor inhibition on carcinogenesis ... this increased risk can be attributed to the use of cytokine inhibitors, to the underlying disease, or to other ...

Several studies have shown that tumor necrosis factor (TNF) inhibitors are associated ... immunosuppressive regimens in patients with rheumatoid arthritis (RA). A study by Strangfeld et al.

Targeted drugs for rheumatoid ... inhibitors reported decreases in pain that were an average of 4.0 points greater (95% CI ...

Please provide your email address to receive an email when new articles are posted on . Patients treated with TNF inhibitors had respiratory hospitalization and mortality rates similar to patients ...

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid arthritis (RA) are unfounded, at least for U.S. military veterans ...

Investigators used Veterans Administration data to assess the relationship among rheumatoid ... rheumatoid arthritis patients treated with triple therapy or tumor necrosis factor inhibitor.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.